Belharra’s Rachel Lane and Sherry Niessen Featured in Genetic Engineering & Biotechnology Article on Protein-Protein Interactions

We are excited to have Chief Business Officer Rachel Lane and Vice President of Proteomics Sherry Niessen featured in an article on protein-protein interactions in Genetic Engineering & Biotechnology News. Rachel and Sherry spoke about the importance of finding novel approaches to access undruggable protein targets by using chemical probes.

Read more:



Belharra CEO Jeff Jonker Talks with Endpoint News About New “Birth of a Biotech” Podcast Series

Our CEO Jeff Jonker sat down with Endpoint News to discuss Belharra’s new podcast series “Birth of a Biotech.” In the article he discusses the reason behind starting the seven-episode podcast series and his hopes for creating something that will start a conversation on research, clinical developments, and patient treatments.

Read more:



Birth of a Biotech Podcast and Belharra CEO Featured in Fierce Pharma Article

We are honored to have Fierce Pharma feature Belharra in an article about our Birth of a Biotech podcast and the history behind how we got where we are today. The article also features Belharra’s CEO, Jeff Jonker, who talks about what makes the podcast resonate so well with listeners.

Read more:



Belharra CEO Jeff Jonker Joins Award-winning Biotech Journalist Luke Timmerman on the 150th Episode of The Long Run Podcast

We were so honored to have our CEO Jeff Jonker be a guest on The Long Run with Luke Timmerman, a biotech podcast that focuses on innovations and emerging trends for anyone seeking to understand new drug development diagnostics, genomics, and other technologies that are changing medicine. Jeff spoke with Luke in a podcast titled “The Small Molecule Drug Discovery Renaissance.”

Listen here: